Checkpoint Therapeutics

-$0.07 (-2.55%) Today
+$0.02 (+0.75%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CKPT and other ETFs, options, and stocks.

About CKPT

Checkpoint Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. Its product portfolio include CK-301, CK-101, CK-103, CK-302, and Anti-CAIX.

CEO
James F. Oliviero
Employees
10
Headquarters
New York, New York
Founded
2014

CKPT Key Statistics

Market Cap
211.42M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.07M
High Today
$2.75
Low Today
$2.64
Open Price
$2.72
Volume
629.77K
52 Week High
$5.38
52 Week Low
$1.90

CKPT Earnings

-$0.22
-$0.15
-$0.07
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 5, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure